OrthoPediatrics Corp. (KIDS)

Market Cap	600.85M
Revenue (ttm)	204.73M
Net Income (ttm)	-37.82M
Shares Out	24.29M
EPS (ttm)	-1.64
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	120,725
Open	24.68
Previous Close	24.75
Day's Range	24.37 - 25.21
52-Week Range	21.02 - 35.99
Beta	1.22
Analysts	Buy
Price Target	37.33 (+50.89%)
Earnings Date	Mar 4, 2025

About KIDS

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity in children; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruct...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Oct 12, 2017
• Employees: 562
• Stock Exchange: NASDAQ
• Ticker Symbol: KIDS
• Website: https://www.orthopediatrics.com

Financial Performance

In 2024, OrthoPediatrics's revenue was $204.73 million, an increase of 37.65% compared to the previous year's $148.73 million. Losses were -$37.82 million, 80.3% more than in 2023.

Analyst Forecast

According to 6 analysts, the average rating for KIDS stock is "Buy." The 12-month stock price forecast is $37.33, which is an increase of 50.89% from the latest price.

Price Target

$37.33

(50.89% upside)

Analyst Consensus: Buy